This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Malaria  • Alert me on articles by topic

A Call for Papers

Catherine D. DeAngelis, MD, MPH; Gianna Zuccotti, MD, MPH

JAMA. 2006;296:1289.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Malaria is an ancient disease, with descriptions of a disease resembling malaria that date back more than 4000 years.¹ There have been many advances in malaria research, including the discovery of the malaria parasite in 1880 by Laveran, for which he was awarded the Nobel Prize in 1904¹; the control of mosquitoes responsible for disease transmission in the early part of the 20th century; the discovery of the antimalarial drug, chloroquine, in 1934 by Andersag; the use of dichlorodiphenyltrichloroethane (DDT) as an insecticidal agent beginning in 1939 that was followed by the use of less toxic insecticides¹; and the discovery and use of other antimalarial drugs and drug combinations, including sulfadoxine-pyrimethamine, mefloquine, atovaquone-proguanic, quinine, and doxycycline.²

Despite these advances, more than a million individuals, mostly children, die every year from malaria and approximately 3 billion people in 107 countries . . . [Full Text of this Article]

Author Affiliations: Dr DeAngelis is Editor in Chief (cathy.deangelis@jama-archives.org) and Dr Zuccotti is Contributing Editor, JAMA.